Minimal residual disease-directed immunotherapy for high-risk myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation

所属期刊栏目：13

资助基金：The authors thank Editage for their English editing assistance as well as Drs.Daoxing Deng,Yujia Chi,and Wei Guo for their assistance in data collection.This work was supported by the Capital”s Funds for Health Improvement and Research2018-4-4089;the Key Program of the National Natural Science Foundation of China81530046;Foundation for Innovative Research Groups of the National Natural Science Foundation of China81621001;the Science and Technology Project of Guangdong Province of China2016B030230003;the National Science and Technology Support Program2014BAI09B13;the Project of Health Collaborative Innovation of Guangzhou city201704020214

在线出版日期：2019-07-04（万方平台首次上网日期，不代表论文的发表时间）

页数：共11页

页码：354-364